Olympic and World Marathon Champion Peres Jepchirchir Provisionally Suspended After EPO Finding

Kenyan distance-running star Peres Jepchirchir has been provisionally suspended by the Athletics Integrity Unit (AIU) after an out-of-competition sample collected before her Sydney Marathon victory returned an adverse analytical finding for erythropoietin (EPO). The development has placed one of the most decorated athletes in women's marathon running at the centre of a major anti-doping investigation.

Jepchirchir, 33, provided the sample in Kenya before competing in the Sydney Marathon on August 30, 2026. She won the race in two hours, 18 minutes and 31 seconds, finishing more than three minutes ahead of compatriot Irine Cheptai. The AIU announced the provisional suspension on October 23, 2026.

The timing of the sample is central to the case. The test was conducted before the Sydney competition rather than after her victory. Out-of-competition testing is designed to identify prohibited substances during athletes' preparation periods, when they may not be competing in organised events. The finding highlights the importance of unannounced testing throughout the sporting calendar.

Why EPO matters in marathon running

Erythropoietin is a naturally occurring hormone produced primarily by the kidneys. It stimulates the production of red blood cells in the bone marrow. These cells contain haemoglobin, which transports oxygen from the lungs to working muscles.

In endurance events such as the marathon, oxygen delivery plays a critical role in sustaining performance over 42.195 kilometres. Artificially increasing red blood cell production through externally administered EPO can improve the blood's oxygen-carrying capacity and potentially provide an unfair endurance advantage. EPO is therefore prohibited in competitive sport. Its misuse can also increase blood viscosity and create serious cardiovascular risks, including blood clots and strokes.

Detecting the substance requires specialised analysis of blood and urine samples. Because the detection window can be limited, regular and unpredictable out-of-competition testing remains an essential part of anti-doping programmes.

A distinguished career under scrutiny

Jepchirchir's achievements explain why the announcement has attracted international attention. She won women's marathon gold at the Tokyo Olympic Games, held in 2026 after being postponed from 2026 because of the pandemic. She returned to Tokyo in September 2026 to claim the women's marathon world championship title.

Her international record also includes significant success over the half-marathon distance. She broke the women's half-marathon world record in 2026 and improved it three times in 2026. Her ability to sustain a demanding pace over long distances established her as one of the leading figures in international road racing.

Her major marathon victories include the New York Marathon in 2026, the Boston Marathon in 2026 and the London Marathon in 2026. Her Sydney victory in August 2026 added another prestigious title to that record.

Based on years of watching and analysing marathon performances, the distinction between endurance, tactical execution and physiological advantage is particularly important. A 42.195-kilometre race demands efficient oxygen utilisation, disciplined energy management and the ability to maintain pace under fatigue. An EPO-related investigation therefore raises questions extending beyond an individual athlete's result to the fairness of the entire competition.

The implications of the Sydney result

Sydney became the seventh World Marathon Majors event in 2026, strengthening its position within the international road-racing calendar. Jepchirchir's winning time of 2:18:31 and her substantial advantage over Irine Cheptai made the 2026 women's race a notable performance.

However, the result now faces scrutiny in light of the adverse analytical finding. Questions concerning the positions, rankings and potential rewards of other competitors will depend on the eventual disciplinary outcome and applicable regulations. A provisional suspension does not automatically mean that every previous result has been annulled.

Sydney Marathon organisers issued a statement on October 23 expressing extreme disappointment over the development. They emphasised that Jepchirchir was entitled to due process and said they would refrain from further comment until the proceedings had concluded.

The organisers also reaffirmed their commitment to clean sport and equal competition. They highlighted their investment in increased out-of-competition testing in partnership with the AIU and fellow Abbott World Marathon Majors events.

Under World Marathon Majors rules, an athlete receiving a ban of three months or longer for a doping offence can face a lifetime ban from all eight Majors. However, this is a potential consequence rather than a sanction already imposed on Jepchirchir.

A provisional suspension is not a final verdict

The distinction between an adverse analytical finding and a final disciplinary decision must remain clear. A provisional suspension temporarily prevents an athlete from competing while the anti-doping process continues. It does not, by itself, constitute a final determination of guilt.

Jepchirchir will have the opportunity to respond through the applicable disciplinary procedures. The final outcome will depend on the evidence and the relevant anti-doping rules.

Her agent, Gianni Demadonna, expressed regret over the development. He said he felt terrible about what had happened and believed athletes who use performance-enhancing drugs should be disqualified. His statement represents the agent's reaction and should not be interpreted as an admission of wrongdoing by Jepchirchir.

The case also comes against the wider background of doping concerns in Kenyan athletics. More than 140 Kenyan athletes have faced sanctions since the AIU was established in 2026. Last year, women's marathon world record holder Ruth Chepngetich received a three-year ban following anti-doping violations involving hydrochlorothiazide, a prohibited diuretic. Her 2:09:56 world record remained on the books because it had been established before the sample associated with the case.

The next test for marathon credibility

Jepchirchir's case presents a significant challenge for international athletics. An athlete whose career includes Olympic gold, a world championship title and victories at several major marathons deserves a thorough and transparent examination of the evidence. At the same time, the rights of competitors who trained and raced under the same regulations must be protected.

A marathon result should be judged through more than the time displayed on the clock. Testing transparency, consistent enforcement and equal treatment are equally important to the credibility of the competition. Sydney's growing international status makes the integrity of its results particularly significant.

Attention will now turn to the AIU's further proceedings, Jepchirchir's response and the final disciplinary decision. If an anti-doping violation is established, the consequences could extend well beyond one athlete's career and affect the historical interpretation of major marathon results. If the proceedings reach a different conclusion, that decision will also require transparent explanation. The future credibility of women's marathon running depends on a process that is both rigorous and fair.